Russia's Sputnik V vaccine 91.6 percent effective against symptomatic COVID-19 in interim analysis

Russia's coronavirus vaccine
(Image credit: Getty Images)

Russia's Sputnik V vaccine has been found in an interim analysis to be 91.6 percent effective against symptomatic COVID-19.

The interim phase 3 trial analysis for Russia's vaccine was confirmed in a peer review from the medical journal The Lancet, which showed that it provided full protection against moderate and severe COVID-19 cases, the Financial Times reports.

Subscribe to The Week

Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

SUBSCRIBE & SAVE
https://cdn.mos.cms.futurecdn.net/flexiimages/jacafc5zvs1692883516.jpg

Sign up for The Week's Free Newsletters

From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.

From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.

Sign up
To continue reading this article...
Continue reading this article and get limited website access each month.
Get unlimited website access, exclusive newsletters plus much more.
Cancel or pause at any time.
Already a subscriber to The Week?
Not sure which email you used for your subscription? Contact us
Brendan Morrow

Brendan worked as a culture writer at The Week from 2018 to 2023, covering the entertainment industry, including film reviews, television recaps, awards season, the box office, major movie franchises and Hollywood gossip. He has written about film and television for outlets including Bloody Disgusting, Showbiz Cheat Sheet, Heavy and The Celebrity Cafe.